ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CEBPA |
P49715
|
CCAAT enhancer binding protein alpha
|
Transcription factor
|
0.55 |
0.496 |
0.692 |
CSF1R |
P07333
|
colony stimulating factor 1 receptor
|
Kinase
|
0.13 |
0.448 |
0.808 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |
CTNNA1 |
P35221
|
catenin alpha 1
|
Cellular structure
|
0.97 |
0.584 |
0.538 |
DAPK1 |
P53355
|
death associated protein kinase 1
|
Kinase
|
1.00 |
0.472 |
0.808 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
FHL2 |
Q14192
|
four and a half LIM domains 2
|
Transcription factor
|
2.9E-05 |
0.556 |
0.731 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
GFI1 |
Q99684
|
growth factor independent 1 transcriptional repressor
|
Transcription factor
|
0.25 |
0.546 |
0.769 |
HOXA9 |
P31269
|
homeobox A9
|
|
4.4E-05 |
0.521 |
0.692 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
IDH2 |
P48735
|
isocitrate dehydrogenase (NADP(+)) 2
|
|
0.88 |
0.434 |
0.808 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |